BDBM50301253 4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)-2-methylpropyl)phenyl)butanamide::CHEMBL577917

SMILES [#6]C([#6])([#6]-c1ccc(-[#7]-[#6](=O)-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])cc1)[#7]-[#6]-[#6](-[#8])-c1ccc(-[#8])c2-[#7]-[#6](=O)-[#6]-[#8]-c12

InChI Key InChIKey=KRTHJCYGNSJFOY-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50301253   

TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301253(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Affinity DataEC50:  1.80nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301253(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed